NPS Pharmaceuticals, Inc. (NPSP) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Loss before income tax expense: -1.93M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Loss before income tax expense: -1.93M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $27.21 million versus the consensus estimate of $24.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
